The minimal important difference of exercise tests in severe COPD
- PMID: 20693247
- PMCID: PMC5516638
- DOI: 10.1183/09031936.00063810
The minimal important difference of exercise tests in severe COPD
Abstract
Our aim was to determine the minimal important difference (MID) for 6-min walk distance (6MWD) and maximal cycle exercise capacity (MCEC) in patients with severe chronic obstructive pulmonary disease (COPD). 1,218 patients enrolled in the National Emphysema Treatment Trial completed exercise tests before and after 4-6 weeks of pre-trial rehabilitation, and 6 months after randomisation to surgery or medical care. The St George's Respiratory Questionnaire (domain and total scores) and University of California San Diego Shortness of Breath Questionnaire (total score) served as anchors for anchor-based MID estimates. In order to calculate distribution-based estimates, we used the standard error of measurement, Cohen's effect size and the empirical rule effect size. Anchor-based estimates for the 6MWD were 18.9 m (95% CI 18.1-20.1 m), 24.2 m (95% CI 23.4-25.4 m), 24.6 m (95% CI 23.4-25.7 m) and 26.4 m (95% CI 25.4-27.4 m), which were similar to distribution-based MID estimates of 25.7, 26.8 and 30.6 m. For MCEC, anchor-based estimates for the MID were 2.2 W (95% CI 2.0-2.4 W), 3.2 W (95% CI 3.0-3.4 W), 3.2 W (95% CI 3.0-3.4 W) and 3.3 W (95% CI 3.0-3.5 W), while distribution-based estimates were 5.3 and 5.5 W. We suggest a MID of 26 ± 2 m for 6MWD and 4 ± 1 W for MCEC for patients with severe COPD.
Conflict of interest statement
A statement of interest for N.N. Hansel can be found at
Comment in
-
How important is a minimal difference?Eur Respir J. 2011 Apr;37(4):755-6. doi: 10.1183/09031936.00156410. Eur Respir J. 2011. PMID: 21454895 No abstract available.
-
Limitations of calculating "true" regression slope: impact on estimates of minimal important difference.Eur Respir J. 2011 May;37(5):1296-7; author reply 1297. doi: 10.1183/09031936.00170910. Eur Respir J. 2011. PMID: 21532023 No abstract available.
References
-
- Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2004;(4):CD003793. - PubMed
-
- Peytremann-Bridevaux I, Staeger P, Bridevaux PO, et al. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med. 2008;121:433–443. - PubMed
-
- Puhan MA, Garcia-Aymerich J, Frey M, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374:704–711. - PubMed
-
- Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23:28–33. - PubMed
-
- Tojo N, Ichioka M, Chida M, et al. Pulmonary exercise testing predicts prognosis in patients with chronic obstructive pulmonary disease. Intern Med. 2005;44:20–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HR076103/HL/NHLBI NIH HHS/United States
- N01HR76115/HR/NHLBI NIH HHS/United States
- N01 HR076102/HL/NHLBI NIH HHS/United States
- N01 HR076114/HL/NHLBI NIH HHS/United States
- N01 HR076113/HL/NHLBI NIH HHS/United States
- N01 HR076104/HL/NHLBI NIH HHS/United States
- N01 HR076101/HL/NHLBI NIH HHS/United States
- N01 HR076110/HL/NHLBI NIH HHS/United States
- N01 HR076112/HL/NHLBI NIH HHS/United States
- N01 HR076109/HL/NHLBI NIH HHS/United States
- N01 HR076105/HL/NHLBI NIH HHS/United States
- N01 HR076118/HL/NHLBI NIH HHS/United States
- N01 HR076115/HR/NHLBI NIH HHS/United States
- N01 HR076107/HL/NHLBI NIH HHS/United States
- N01 HR076106/HL/NHLBI NIH HHS/United States
- N01 HR076119/HL/NHLBI NIH HHS/United States
- N01 HR076108/HL/NHLBI NIH HHS/United States
- N01 HR076116/HL/NHLBI NIH HHS/United States
- N01 HR076111/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical